Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Generic Sterile Injectable Market, Global Research Reports 2020-2021

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Generic Sterile Injectable Industry
  • 1.7 COVID-19 Impact: Generic Sterile Injectable Market Trends

    • 2 Global Generic Sterile Injectable Quarterly Market Size Analysis

    • 2.1 Generic Sterile Injectable Business Impact Assessment - COVID-19
      • 2.1.1 Global Generic Sterile Injectable Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Generic Sterile Injectable Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Generic Sterile Injectable Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Generic Sterile Injectable Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Generic Sterile Injectable Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Generic Sterile Injectable Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Generic Sterile Injectable Market
    • 3.5 Key Manufacturers Generic Sterile Injectable Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Generic Sterile Injectable Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Monoclonal Antibodies
      • 1.4.2 Cytokines
      • 1.4.3 Insulin
      • 1.4.4 Peptide Hormones
      • 1.4.5 Vaccines
      • 1.4.6 Others
    • 4.2 By Type, Global Generic Sterile Injectable Market Size, 2019-2021
      • 4.2.1 By Type, Global Generic Sterile Injectable Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Generic Sterile Injectable Price, 2020-2021

    5 Impact of Covid-19 on Generic Sterile Injectable Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hospitals
      • 5.5.2 Pharmacies
      • 5.5.3 Online Pharmacies
    • 5.2 By Application, Global Generic Sterile Injectable Market Size, 2019-2021
      • 5.2.1 By Application, Global Generic Sterile Injectable Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Generic Sterile Injectable Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 3M
      • 7.1.1 3M Business Overview
      • 7.1.2 3M Generic Sterile Injectable Quarterly Production and Revenue, 2020
      • 7.1.3 3M Generic Sterile Injectable Product Introduction
      • 7.1.4 3M Response to COVID-19 and Related Developments
    • 7.2 Baxter Inc
      • 7.2.1 Baxter Inc Business Overview
      • 7.2.2 Baxter Inc Generic Sterile Injectable Quarterly Production and Revenue, 2020
      • 7.2.3 Baxter Inc Generic Sterile Injectable Product Introduction
      • 7.2.4 Baxter Inc Response to COVID-19 and Related Developments
    • 7.3 Fresenius Kabi
      • 7.3.1 Fresenius Kabi Business Overview
      • 7.3.2 Fresenius Kabi Generic Sterile Injectable Quarterly Production and Revenue, 2020
      • 7.3.3 Fresenius Kabi Generic Sterile Injectable Product Introduction
      • 7.3.4 Fresenius Kabi Response to COVID-19 and Related Developments
    • 7.4 Pfizer/Hospira
      • 7.4.1 Pfizer/Hospira Business Overview
      • 7.4.2 Pfizer/Hospira Generic Sterile Injectable Quarterly Production and Revenue, 2020
      • 7.4.3 Pfizer/Hospira Generic Sterile Injectable Product Introduction
      • 7.4.4 Pfizer/Hospira Response to COVID-19 and Related Developments
    • 7.5 Novartis/Sandoz
      • 7.5.1 Novartis/Sandoz Business Overview
      • 7.5.2 Novartis/Sandoz Generic Sterile Injectable Quarterly Production and Revenue, 2020
      • 7.5.3 Novartis/Sandoz Generic Sterile Injectable Product Introduction
      • 7.5.4 Novartis/Sandoz Response to COVID-19 and Related Developments
    • 7.6 Teva
      • 7.6.1 Teva Business Overview
      • 7.6.2 Teva Generic Sterile Injectable Quarterly Production and Revenue, 2020
      • 7.6.3 Teva Generic Sterile Injectable Product Introduction
      • 7.6.4 Teva Response to COVID-19 and Related Developments
    • 7.7 Hikma
      • 7.7.1 Hikma Business Overview
      • 7.7.2 Hikma Generic Sterile Injectable Quarterly Production and Revenue, 2020
      • 7.7.3 Hikma Generic Sterile Injectable Product Introduction
      • 7.7.4 Hikma Response to COVID-19 and Related Developments
    • 7.8 Sun Pharma
      • 7.8.1 Sun Pharma Business Overview
      • 7.8.2 Sun Pharma Generic Sterile Injectable Quarterly Production and Revenue, 2020
      • 7.8.3 Sun Pharma Generic Sterile Injectable Product Introduction
      • 7.8.4 Sun Pharma Response to COVID-19 and Related Developments
    • 7.9 Dr. Reddy’s
      • 7.9.1 Dr. Reddy’s Business Overview
      • 7.9.2 Dr. Reddy’s Generic Sterile Injectable Quarterly Production and Revenue, 2020
      • 7.9.3 Dr. Reddy’s Generic Sterile Injectable Product Introduction
      • 7.9.4 Dr. Reddy’s Response to COVID-19 and Related Developments
    • 7.10 Mylan
      • 7.10.1 Mylan Business Overview
      • 7.10.2 Mylan Generic Sterile Injectable Quarterly Production and Revenue, 2020
      • 7.10.3 Mylan Generic Sterile Injectable Product Introduction
      • 7.10.4 Mylan Response to COVID-19 and Related Developments
    • 7.11 AstraZeneca Plc
      • 7.11.1 AstraZeneca Plc Business Overview
      • 7.11.2 AstraZeneca Plc Generic Sterile Injectable Quarterly Production and Revenue, 2020
      • 7.11.3 AstraZeneca Plc Generic Sterile Injectable Product Introduction
      • 7.11.4 AstraZeneca Plc Response to COVID-19 and Related Developments
    • 7.12 Merck & Co., Inc
      • 7.12.1 Merck & Co., Inc Business Overview
      • 7.12.2 Merck & Co., Inc Generic Sterile Injectable Quarterly Production and Revenue, 2020
      • 7.12.3 Merck & Co., Inc Generic Sterile Injectable Product Introduction
      • 7.12.4 Merck & Co., Inc Response to COVID-19 and Related Developments
    • 7.13 Hellberg Safety Ab
      • 7.13.1 Hellberg Safety Ab Business Overview
      • 7.13.2 Hellberg Safety Ab Generic Sterile Injectable Quarterly Production and Revenue, 2020
      • 7.13.3 Hellberg Safety Ab Generic Sterile Injectable Product Introduction
      • 7.13.4 Hellberg Safety Ab Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Generic Sterile Injectable Supply Chain Analysis
      • 8.1.1 Generic Sterile Injectable Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Generic Sterile Injectable Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Generic Sterile Injectable Distribution Channels
      • 8.2.2 Covid-19 Impact on Generic Sterile Injectable Distribution Channels
      • 8.2.3 Generic Sterile Injectable Distributors
    • 8.3 Generic Sterile Injectable Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Generic Sterile Injectable, including the following market information:
      Global Generic Sterile Injectable Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Generic Sterile Injectable Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Generic Sterile Injectable Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Generic Sterile Injectable Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include 3M, Baxter Inc, Fresenius Kabi, Pfizer/Hospira, Novartis/Sandoz, Teva, Hikma, Sun Pharma, Dr. Reddy’s, Mylan, AstraZeneca Plc, Merck & Co., Inc, Hellberg Safety Ab, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Monoclonal Antibodies
      Cytokines
      Insulin
      Peptide Hormones
      Vaccines
      Others

      Based on the Application:
      Hospitals
      Pharmacies
      Online Pharmacies

      Buy now